Prostate hypertrophy resection resummation, ejaculation disorder side effects low
Mar 13, 2025
|
Choi Se-young, a professor of urology at Chung-Ang University Hospital, presented a research abstract on the improvement effect of Rezum in the treatment of prostate hypertrophy at the International Symposium (2025 KPS Annual Prostate International Meeting) hosted by the Korean Prostate Society on March 7-8.
Professor Choi Se-young was selected as the winner of the 「Excellent Academic Award" in recognition of the excellence of meta-analysis research by comparing the treatment of prostate hypertrophy with the existing conductive ablation, and was honored with the award for the fourth consecutive year at an international academic conference hosted by the Korean National Front Association.
In this study, Professor Choi evaluated the effectiveness and safety of prostate hypertrophy treatment by comparing the urethral prostatectomy method 'Reezum', which uses heated water vapor to necrotize the enlarged prostate at the moment it was recently recognized as a new medical technology, with the traditionally widely performed 'Reezum' surgery method 'TUR-P' and'Conductive Surgery (TUMT, TUNA)' which are not currently being implemented in Korea.
As a result, it was confirmed that 'Reezum' showed similar effects to conventional resection in terms of the prostate symptom score, quality of life, maximum urine flow, and residual urine, and that the incidence of acute urinary retention did not differ significantly from other methods.
In particular, the incidence of ejaculation (射精) dysfunction in 'Reezum' treatment was found to be 2 to 3%, the lowest among surgical techniques compared together, suggesting that 'Reezum' could be an excellent treatment option in terms of function preservation among minimally invasive treatments.
Professor Choi Se-young noted that "'Reezum' treatment has an equivalent effect in terms of functional outcomes compared to conventional prostatectomy, but has a lower incidence of ejaculation dysfunction, which is important, especially in male patients, "Reezum' through this study demonstrated that 'Reezum' could be an important option in the treatment of minimally invasive prostate hyperplasia." he said.
Meanwhile, the department of urology at Chung-Ang University Hospital recently introduced a resummation device for the treatment of minimally invasive prostate hypertrophy and is conducting full-scale treatment.
Rezum is a treatment that naturally reduces and necrotizes the enlarged tissue by delivering high-temperature water vapor to prostate tissue, which has the advantage of shorter surgery time than conventional surgical treatments and being able to perform procedures without general anesthesia.
Professor Choi Se-young said "Rizum is attracting attention as a suitable treatment option for patients who want to live an active life because it preserves the ejaculation function and improves symptoms.", and "The department of urology at Chung-Ang University Hospital is providing a better treatment environment for patients through the introduction of the latest medical technology, and is actively implementing prostate hypertrophy treatment using Rezoom".
|
This article was translated by Naver AI translator.
